New
Our co-authored paper titled Emerging drugs for the treatment of vitiligo has been published in the journal Expert Opinion on Emerging Drugs.
This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treatment in current research, followed by antioxidant and repigmenting mechanisms, basic fibroblast growth factors, afamelanotide and targeted immunotherapy.
For more information about emerging treatments for vitiligo, check out Drug Pipelines or Trials Hub sections of our website.
We also recommend reading our exclusive Vitiligo Drug Pipeline Analysis and Market Insights.
FAQOther Questions
- Is there a traditional medicine to treat vitiligo?
Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...
- How can I explain vitiligo to my children?
Vitiligo can be puzzling for a child because a person who has it isn't "ill" in a common sense. To choose the right words to explain vitiligo diagnosis to a child, first consi...
- Vitiligo and hearing loss: any connection?
Vitiligo, primarily known for skin discoloration, can also affect melanocytes in the inner ear, potentially influencing hearing. Hearing loss isn't unique to vitiligo patients a...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.